BRPI0519507A2 - uso de fàrmula lactente com teor de proteÍna reduzido - Google Patents
uso de fàrmula lactente com teor de proteÍna reduzidoInfo
- Publication number
- BRPI0519507A2 BRPI0519507A2 BRPI0519507-1A BRPI0519507A BRPI0519507A2 BR PI0519507 A2 BRPI0519507 A2 BR PI0519507A2 BR PI0519507 A BRPI0519507 A BR PI0519507A BR PI0519507 A2 BRPI0519507 A2 BR PI0519507A2
- Authority
- BR
- Brazil
- Prior art keywords
- reduced protein
- infant formula
- igf
- infant
- life
- Prior art date
Links
- 102000004169 proteins and genes Human genes 0.000 title abstract 3
- 108090000623 proteins and genes Proteins 0.000 title abstract 3
- 235000013350 formula milk Nutrition 0.000 title 1
- 101000599951 Homo sapiens Insulin-like growth factor I Proteins 0.000 abstract 3
- 102100037852 Insulin-like growth factor I Human genes 0.000 abstract 3
- 235000016709 nutrition Nutrition 0.000 abstract 2
- 208000008589 Obesity Diseases 0.000 abstract 1
- 235000020824 obesity Nutrition 0.000 abstract 1
- 230000026267 regulation of growth Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/19—Dairy proteins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Mycology (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Nutrition Science (AREA)
- Pediatric Medicine (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Child & Adolescent Psychology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Animal Behavior & Ethology (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Dairy Products (AREA)
Abstract
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP04030371 | 2004-12-27 | ||
PCT/EP2005/056774 WO2006069918A1 (en) | 2004-12-27 | 2005-12-14 | Use of infant formula with reduced protein content |
Publications (1)
Publication Number | Publication Date |
---|---|
BRPI0519507A2 true BRPI0519507A2 (pt) | 2009-03-10 |
Family
ID=34927903
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI0519507-1A BRPI0519507A2 (pt) | 2004-12-27 | 2005-12-14 | uso de fàrmula lactente com teor de proteÍna reduzido |
Country Status (18)
Country | Link |
---|---|
US (2) | US20100022451A1 (pt) |
EP (1) | EP1841330B1 (pt) |
CN (1) | CN101087539A (pt) |
AR (1) | AR052074A1 (pt) |
AT (1) | ATE498324T1 (pt) |
AU (1) | AU2005321326B2 (pt) |
BR (1) | BRPI0519507A2 (pt) |
CA (1) | CA2593033A1 (pt) |
DE (1) | DE602005026456D1 (pt) |
ES (1) | ES2359573T3 (pt) |
MX (1) | MX2007007898A (pt) |
MY (1) | MY144008A (pt) |
PL (1) | PL1841330T3 (pt) |
PT (1) | PT1841330E (pt) |
RU (1) | RU2390269C2 (pt) |
TW (1) | TWI365045B (pt) |
WO (1) | WO2006069918A1 (pt) |
ZA (1) | ZA200706201B (pt) |
Families Citing this family (35)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20050175759A1 (en) | 2004-02-09 | 2005-08-11 | Atul Singhal | Newborn infant formulas and feeding methods |
US8815279B2 (en) | 2003-02-10 | 2014-08-26 | University College London | Baby feeding formula and system |
BRPI0620466A2 (pt) | 2005-12-22 | 2011-11-16 | Nutricia Nv | uso de uma composição |
WO2008054192A1 (en) * | 2006-11-02 | 2008-05-08 | N.V. Nutricia | Use of nutritional compositions for preventing disorders |
ES2366034T3 (es) | 2005-12-23 | 2011-10-14 | N.V. Nutricia | Composición que comprende ácidos grasos poliinsaturados, proteínas, manganeso y/o molibdeno y nucleósidos/nucleótidos para el tratamiento de la demencia. |
EP1932437A1 (en) * | 2006-12-15 | 2008-06-18 | Nestec S.A. | Infant formula |
US8361534B2 (en) | 2007-12-20 | 2013-01-29 | Abbott Laboratories | Stable nutritional powder |
AR072141A1 (es) | 2008-06-13 | 2010-08-11 | Nutricia Nv | Composicion nutricional para lactantes nacidos por cesarea |
US20100006459A1 (en) * | 2008-07-10 | 2010-01-14 | Ann Foley | Dry cleaning bag |
EP2452574A1 (en) | 2010-11-15 | 2012-05-16 | Nestec S.A. | Age-tailored nutritional formula with particularly adapted caloric density for young infants |
CA2745246A1 (en) | 2008-12-08 | 2010-06-17 | Nestec S.A. | Modulation of infant fat mass |
EP2373184A4 (en) * | 2008-12-17 | 2012-08-29 | Igeloesa Nutrition Science Ab | FOOD SUPPLEMENT WITH SPECIFIC AMINO ACID PROFILE |
WO2010070613A2 (en) * | 2008-12-18 | 2010-06-24 | University College London | Baby feeding formula and system |
WO2010119088A2 (en) * | 2009-04-15 | 2010-10-21 | Bodo Melnik | Milk and milk-based products modified to exhibit a reduced insulinemic index and/or reduced mitogenic activity |
HUE026180T2 (en) * | 2010-12-06 | 2016-05-30 | Nutricia Nv | Fermented Child Nutrition |
EP2520181A1 (en) * | 2011-05-02 | 2012-11-07 | N.V. Nutricia | Fermented infant formula |
EP2514435A1 (en) | 2011-04-19 | 2012-10-24 | Nestec S.A. | Infant formula for use in the prevention of cardiovascular diseases |
EP2583562A1 (en) | 2011-10-21 | 2013-04-24 | Nestec S.A. | Use of whey protein micelles for infants at risk of obesity or diabetes |
SE536599C3 (sv) | 2012-04-10 | 2017-01-10 | Hero Ag | Näringssammansättning med lågt kalori- och lågt proteininnehåll |
US9210947B2 (en) | 2012-05-11 | 2015-12-15 | N.V. Nutricia | Infant formulae and their preparations |
WO2013187755A1 (en) * | 2012-06-14 | 2013-12-19 | N.V. Nutricia | Fermented infant formula with non digestible oligosaccharides |
BR112015019223A2 (pt) * | 2013-02-12 | 2017-07-18 | Univ Southern California | método para prolongar a longevidade de um indivíduo; método para diminuir os níveis de glicose e/ou igf-1 em um indivíduo; método para aliviar um sintoma de quimiotoxicidade em um indivíduo; e método para tratar a quimiotoxicidade em um indivíduo |
BR112016009357B1 (pt) | 2013-11-04 | 2021-09-14 | N.V. Nutricia | Usos de um ingrediente fermentado e oligossacarídeos não digeríveis na fabricação de uma fórmula para fórmula para recém-nascido ou de continuação para uso na redução da incidência de cólicas em um recém-nascido |
AU2014356449B2 (en) | 2013-11-29 | 2018-07-26 | Société des Produits Nestlé S.A. | Age-tailored nutritional compositions with a varying protein content |
EP3082462A1 (en) * | 2013-11-29 | 2016-10-26 | Nestec S.A. | Nutritional compositions with phospholipids |
WO2015085555A1 (en) * | 2013-12-12 | 2015-06-18 | Nestec S.A. | Array of age-tailored infant formula with optimum protein content and lactose content |
US10639334B2 (en) * | 2014-01-07 | 2020-05-05 | Mead Johnson Nutrition Company | Pediatric nutritional composition with milk peptides for healthy growth and development |
WO2015154256A1 (en) * | 2014-04-09 | 2015-10-15 | Nestle (China) Ltd. | Gender specific synthetic nutritional compositions and,nutritional systems comprising them |
WO2015154251A1 (en) * | 2014-04-09 | 2015-10-15 | Nestle (China) Ltd. | Gender specific synthetic nutritional compositions and nutritional systems comprising them. |
WO2015154257A1 (en) * | 2014-04-09 | 2015-10-15 | Nestle (China) Ltd. | Gender specific synthetic nutritional compositions and, nutritional systems comprising them |
WO2015154254A1 (en) * | 2014-04-09 | 2015-10-15 | Nestle (China) Ltd. | Gender specific synthetic nutritional compositions and nutritional systems comprising them |
EP3183973A1 (en) * | 2015-12-22 | 2017-06-28 | Agriculture and Food Development Authority (TEAGASC) | A dairy product |
US11197917B2 (en) | 2017-12-01 | 2021-12-14 | ByHeart, Inc. | Formulations for nutritional support in subjects in need thereof |
EP4044828B1 (en) * | 2019-10-17 | 2024-08-07 | Société des Produits Nestlé S.A. | Extensively hydrolysed infant formula |
CN118415243B (zh) * | 2024-07-05 | 2024-11-05 | 内蒙古伊利实业集团股份有限公司 | 可改善芳香族氨基酸生物利用度的营养组合物及其应用 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2371696C (en) * | 1999-04-29 | 2005-11-15 | Societe Des Produits Nestle S.A. | Composition for an infant formula having a low threonine content |
-
2005
- 2005-12-14 PT PT05819164T patent/PT1841330E/pt unknown
- 2005-12-14 PL PL05819164T patent/PL1841330T3/pl unknown
- 2005-12-14 CA CA002593033A patent/CA2593033A1/en not_active Abandoned
- 2005-12-14 ES ES05819164T patent/ES2359573T3/es active Active
- 2005-12-14 US US11/722,339 patent/US20100022451A1/en not_active Abandoned
- 2005-12-14 DE DE602005026456T patent/DE602005026456D1/de active Active
- 2005-12-14 AU AU2005321326A patent/AU2005321326B2/en active Active
- 2005-12-14 BR BRPI0519507-1A patent/BRPI0519507A2/pt not_active IP Right Cessation
- 2005-12-14 AT AT05819164T patent/ATE498324T1/de not_active IP Right Cessation
- 2005-12-14 EP EP05819164A patent/EP1841330B1/en not_active Revoked
- 2005-12-14 RU RU2007128776/13A patent/RU2390269C2/ru active
- 2005-12-14 CN CNA2005800446098A patent/CN101087539A/zh active Pending
- 2005-12-14 WO PCT/EP2005/056774 patent/WO2006069918A1/en active Application Filing
- 2005-12-14 MX MX2007007898A patent/MX2007007898A/es active IP Right Grant
- 2005-12-15 MY MYPI20055904A patent/MY144008A/en unknown
- 2005-12-26 AR ARP050105539A patent/AR052074A1/es not_active Application Discontinuation
- 2005-12-26 TW TW094146575A patent/TWI365045B/zh not_active IP Right Cessation
-
2007
- 2007-07-26 ZA ZA200706201A patent/ZA200706201B/xx unknown
-
2010
- 2010-10-08 US US12/901,048 patent/US20110028389A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
PT1841330E (pt) | 2011-03-14 |
AU2005321326A1 (en) | 2006-07-06 |
ZA200706201B (en) | 2008-10-29 |
ES2359573T3 (es) | 2011-05-24 |
AR052074A1 (es) | 2007-02-28 |
CA2593033A1 (en) | 2006-07-06 |
CN101087539A (zh) | 2007-12-12 |
EP1841330B1 (en) | 2011-02-16 |
PL1841330T3 (pl) | 2011-07-29 |
US20110028389A1 (en) | 2011-02-03 |
MX2007007898A (es) | 2007-08-20 |
RU2390269C2 (ru) | 2010-05-27 |
ATE498324T1 (de) | 2011-03-15 |
TWI365045B (en) | 2012-06-01 |
WO2006069918A1 (en) | 2006-07-06 |
TW200633643A (en) | 2006-10-01 |
AU2005321326B2 (en) | 2011-05-26 |
MY144008A (en) | 2011-07-29 |
US20100022451A1 (en) | 2010-01-28 |
DE602005026456D1 (de) | 2011-03-31 |
RU2007128776A (ru) | 2009-02-10 |
EP1841330A1 (en) | 2007-10-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BRPI0519507A2 (pt) | uso de fàrmula lactente com teor de proteÍna reduzido | |
Kang et al. | The role of selenium metabolism and selenoproteins in cartilage homeostasis and arthropathies | |
Madsen et al. | Stanniocalcin: a novel protein regulating calcium and phosphate transport across mammalian intestine | |
Felsenfeld et al. | Calcitonin, the forgotten hormone: does it deserve to be forgotten? | |
Ma et al. | Hepatic DNA methylation modifications in early development of rats resulting from perinatal BPA exposure contribute to insulin resistance in adulthood | |
Berggren et al. | Effect of selenium on rat thioredoxin reductase activity: increase by supranutritional selenium and decrease by selenium deficiency | |
Lin et al. | L-Glutamate supplementation improves small intestinal architecture and enhances the expressions of jejunal mucosa amino acid receptors and transporters in weaning piglets | |
Tain et al. | Longevity in response to lowered insulin signaling requires glycine N‐methyltransferase‐dependent spermidine production | |
Nielsen | Micronutrients in parenteral nutrition: boron, silicon, and fluoride | |
BR0016341A (pt) | Fórmula para bebês, processo para preparar um hidrolisado protéico, hidrolisado protéico, e, uso de um hidrolisado protéico | |
BR0314799A (pt) | Controle glicêmico aperfeiçoado para pré-diabetes e/ou diabetes do tipo ii usando ácido docosahexaenóico | |
BRPI0600199A (pt) | usos de ácido pinolênico ou um seu derivado e de uma composição | |
BRPI0604538A (pt) | produtos de cereal de conteúdo de umidade elevado com vida útil elevada | |
BRPI0410884A (pt) | composição de ração para uso em um animal de estimação, e, método para o controle de peso em um animal de estimação | |
BRPI0710185A8 (pt) | anticorpos contra receptor de fator de crescimento i semelhante à insulina e usos dos mesmos | |
SG178797A1 (en) | Oligosaccharide chain added glp-1 peptide | |
Lavoie et al. | Altered glycogen metabolism in cultured astrocytes from mice with chronic glutathione deficit; relevance for neuroenergetics in schizophrenia | |
Christov et al. | Insights from genetic disorders of phosphate homeostasis | |
Sahebi Ala et al. | Effects of dietary supplemental methionine source and betaine replacement on the growth performance and activity of mitochondrial respiratory chain enzymes in normal and heat‐stressed broiler chickens | |
BRPI0917562B8 (pt) | composição farmacêutica estabilizada contra oxidação | |
Mak et al. | Myostatin and insulin-like growth factors in uremic sarcopenia: the yin and yang in muscle mass regulation | |
Brown‐Borg | Reduced growth hormone signaling and methionine restriction: interventions that improve metabolic health and extend life span | |
BR112013013112A2 (pt) | uso de uma composição tendo uma densidade de energia entre 0,9 e 1,5 kcal/ml, composição para uso no controle de níveis de colesterol e triglicérides em um paciente que apresenta diabetes tipo 2 | |
BR0213740A (pt) | Processos e composições para uma dieta especifica por gênero de filhotes de animais de estimação | |
Ko et al. | Effect of dietary calcium and 1, 25-(OH) 2D3 on the expression of calcium transport genes in calbindin-D9k and-D28k double knockout mice |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
B07G | Grant request does not fulfill article 229-c lpi (prior consent of anvisa) [chapter 7.7 patent gazette] |
Free format text: NOTIFICACAO DE DEVOLUCAO DO PEDIDO POR NAO SE ENQUADRAR NO ART. 229-C DA LPI. |
|
B09B | Patent application refused [chapter 9.2 patent gazette] |
Free format text: INDEFIRO O PEDIDO DE ACORDO COM O(S) ARTIGO(S) 8, 11, 13 E 25 DA LPI |
|
B12B | Appeal against refusal [chapter 12.2 patent gazette] | ||
B15K | Others concerning applications: alteration of classification |
Ipc: A23L 33/19 (2016.01), A23L 33/00 (2016.01) |
|
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 13A ANUIDADE. |
|
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2494 DE 23-10-2018 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |